Covonia Dry & Tickly Cough Linctus
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Covonia Dry & Tickly Cough Linctus
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1.36g Glycerol BP
Excipients: Each 5ml contains Syrup(sucrose) 2.436gm, Liquid Glucose 280.0mg For full list of excipients see section 6.1
3 PHARMACEUTICAL FORM
Oral Solution
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
A soothing preparation for relief of the symptoms of coughs and sore throats.
4.2 Posology and method of administration
Oral
Recommended doses Adults: two 5ml spoonfuls.
Children over 1 year: one 5ml spoonful.
Dosage schedule When Required.
Shake the bottle.
4.3 Contraindications
Hypersensitivity to any of the ingredients
4.4 Special warnings and precautions for use
Keep all medicines out of the reach and sight of children.
Not suitable for children under 1 year.
Not suitable for use in diabetics.
If symptoms persist, consult your doctor.
4.5 Interaction with other medicinal products and other forms of interaction
None known
4.6 Fertility, pregnancy and lactation
No adverse effects are considered likely if this product is used in the above conditions, however, as with all medicines, its use should be avoided unless recommended by a doctor.
4.7 Effects on ability to drive and use machines
None known
4.8 Undesirable effects
None anticipated at the recommended dosage.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
4.9 Overdose
Overdose with this preparation is unlikely to occur, however, large doses of glycerin may cause thirst, headache, nausea, vomiting, diarrhoea, hyperglycaemia, dehydration, dizziness and mental confusion. Cardiac arrhythmias have been reported. If ingestion is recent gastric lavage should be administered, other treatment should be symptomatic.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Glycerol acts as a demulcent to soothe the passage of the upper respiratory tract.
5.2 Pharmacokinetic properties
Glycerol is readily absorbed from the intestine and is metabolised to carbon dioxide and glycogen.
5.3 Preclinical safety data
None known
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Purified Water Honey Citric Acid Syrup Caramel Menthol Peppermint Oil Anise Oil
Capsicum Tincture (contains capsicum oleoresin, ethanol)
Blackcurrant Flavour (contains propylene glycol, ethanol)
Liquorice Liquid Extract Liquid Glucose
6.2 Incompatibilities
None
6.3 Shelf life
24 months unopened
Use within 28 days of opening
6.4 Special precautions for storage
None
6.5 Nature and contents of container
150ml: glass bottle with 28mm cap with tamper evident band and EPE/Saranex 180ml: glass bottle with 28mm cap with tamper evident band and EPE/Saranex 300ml: glass bottle with 28mm cap with tamper evident band and EPE/Saranex
liner. liner. liner
6.6 Special precautions for disposal
None stated.
7 MARKETING AUTHORISATION HOLDER
Thornton & Ross Ltd Linthwaite Laboratories Huddersfield HD7 5QH ENGLAND
8 MARKETING AUTHORISATION NUMBER(S)
PL 00240/5092R
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION
02/12/1988 / 26/05/2005
10 DATE OF REVISION OF THE TEXT
31/12/2014